關於 Kite Pharma, Inc.
Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.
Source: Wikipedia
產業Biotechnology
總部Santa Monica, CA
成立時間2009
法律形式C Corporation
狀態營運中
專利863 項專利
GPC3 BINDING MOLECULESUS20260242507A1 · 2026
Methods of administering chimeric antigen receptor immunotherapyUS12709639B2 · 2026
關鍵數據
法律資訊
| 法定名稱 | Kite Pharma, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1510580在 SEC EDGAR 上查看 ↗ |
| 登記地址 | Santa Monica, CA |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年11月14日